ES2094035T3 - Utilizacion de un aceptor de espin en una composicion cosmetica o dermatologica. - Google Patents

Utilizacion de un aceptor de espin en una composicion cosmetica o dermatologica.

Info

Publication number
ES2094035T3
ES2094035T3 ES94402979T ES94402979T ES2094035T3 ES 2094035 T3 ES2094035 T3 ES 2094035T3 ES 94402979 T ES94402979 T ES 94402979T ES 94402979 T ES94402979 T ES 94402979T ES 2094035 T3 ES2094035 T3 ES 2094035T3
Authority
ES
Spain
Prior art keywords
cosmetic
dermatological composition
spin
skin
acceptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94402979T
Other languages
English (en)
Inventor
Alain Ribier
Quang Lan Nguyen
Jean-Thierry Simonnet
Boudiaf Boussouira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2094035T3 publication Critical patent/ES2094035T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
    • Y10S977/78—Possessing fully enclosed nanosized voids or physical holes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE UN ACEPTADOR DE ESPIN EMPLEADO COMO SONDA DE MEDICION EN RESONANCIA PARAMAGNETICA ELECTRONICA, EN UNA COMPOSICION COSMETICA O DERMATOLOGICA PARA EL TRATAMIENTO FOTORREACTOR, ANTIENVEJECIMIENTO Y/O ANTIACNEICO DE LA PIEL. ESTE ACEPTADOR DE ESPIN ESTA EN PARTICULAR ENCAPSULADO EN VESICULAS LIPIDICAS APTAS PARA SER DIFUNDIDAS EN LAS CAPAS PROFUNDAS DE LA PIEL
ES94402979T 1993-12-30 1994-12-21 Utilizacion de un aceptor de espin en una composicion cosmetica o dermatologica. Expired - Lifetime ES2094035T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9315869A FR2714604B1 (fr) 1993-12-30 1993-12-30 Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.

Publications (1)

Publication Number Publication Date
ES2094035T3 true ES2094035T3 (es) 1997-01-01

Family

ID=9454572

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94402979T Expired - Lifetime ES2094035T3 (es) 1993-12-30 1994-12-21 Utilizacion de un aceptor de espin en una composicion cosmetica o dermatologica.

Country Status (13)

Country Link
US (2) US5569663A (es)
EP (1) EP0665003B1 (es)
JP (1) JP2736312B2 (es)
CN (1) CN1114876A (es)
AT (1) ATE141782T1 (es)
BR (1) BR9405479A (es)
CA (1) CA2138877A1 (es)
DE (1) DE69400431T2 (es)
ES (1) ES2094035T3 (es)
FR (1) FR2714604B1 (es)
HU (1) HUT71385A (es)
PL (1) PL306581A1 (es)
RU (1) RU2139038C1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US20050107366A1 (en) * 1991-06-18 2005-05-19 Carney John M. Spin trapping pharmaceutical compositions and methods for use thereof
FR2714604B1 (fr) * 1993-12-30 1996-01-26 Oreal Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
AU720476B2 (en) * 1996-05-07 2000-06-01 Eric F. Bernstein Use of tempol in the prevention of photoaging
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
CA2377621C (en) * 1999-06-23 2009-05-19 Eric F. Bernstein Use of nitroxides in wound healing and in the prevention of photodamage
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US20030036749A1 (en) * 1999-12-10 2003-02-20 Durkin Anthony J. Method of treating disorders associated with sebaceous follicles
US6743222B2 (en) 1999-12-10 2004-06-01 Candela Corporation Method of treating disorders associated with sebaceous follicles
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US20030045461A1 (en) * 2001-09-06 2003-03-06 Jen-Chang Hsia Composition and methods of esterified nitroxides gated with carboxylic acids
JP4012058B2 (ja) 2001-12-21 2007-11-21 キヤノン株式会社 リサイクル性重合体、その製造方法、ならびにリサイクル処理方法
FR2846968B1 (fr) * 2002-11-08 2005-02-04 Salles Jean Pierre Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert- butyl nitrone
DE602005022616D1 (de) * 2004-12-22 2010-09-09 Basf Se Mittel gegen radikale
US20060235370A1 (en) * 2005-04-04 2006-10-19 Oblong John E Method of regulating mammalian keratinous tissue
KR20080074901A (ko) * 2005-10-24 2008-08-13 시바 홀딩 인코포레이티드 산화성 물질의 보호
EP2138157B1 (en) * 2005-12-15 2013-05-01 Jarrow Formulas, Inc. Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions
US8246611B2 (en) 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
FR2903012A1 (fr) * 2006-06-29 2008-01-04 Arkema France Utilisation d'un polynitroxyde pour lutter contre les desordes cutane lies aux radicaux libres
WO2008008971A1 (en) * 2006-07-13 2008-01-17 Candela Corporation Compact, handheld device for home-based acne treatment
BR112014012941B1 (pt) * 2011-11-30 2019-04-09 Dow Global Technologies Llc Composição para cuidado pessoal, método cosmético para tratar pele, e, métodos para inibir a degradação de colágeno na pele e para reduzir os sinais visíveis de envelhecimento
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) * 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
FR2315991A1 (fr) * 1975-06-30 1977-01-28 Oreal Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes
JPS5850883A (ja) * 1981-09-21 1983-03-25 Sony Corp 分離フイルタ
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
US4863717A (en) * 1986-11-10 1989-09-05 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging
US4849346A (en) * 1987-02-12 1989-07-18 Regents Of The University Of Minnesota Method for determining thioredoxin reductase activity
JP2554880B2 (ja) * 1987-05-07 1996-11-20 ポーラ化成工業株式会社 皮膚化粧料
FR2655540B1 (fr) * 1989-12-13 1994-02-11 Oreal Composition cosmetique pour le soin des cheveux et utilisation de ladite composition.
US5334756A (en) * 1991-03-26 1994-08-02 Sandoz Ltd. Carboxylate of certain polyoxyalkylene amines
WO1992021017A1 (en) * 1991-05-23 1992-11-26 Unger Evan C Liposoluble compounds for magnetic resonance imaging
FR2687913A1 (fr) * 1992-02-28 1993-09-03 Oreal Composition pour traitement topique contenant des vesicules lipidiques encapsulant au moins une eau minerale.
FR2714604B1 (fr) * 1993-12-30 1996-01-26 Oreal Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.

Also Published As

Publication number Publication date
PL306581A1 (en) 1995-07-10
ATE141782T1 (de) 1996-09-15
JP2736312B2 (ja) 1998-04-02
BR9405479A (pt) 1995-09-19
RU94045130A (ru) 1996-10-20
JPH07324028A (ja) 1995-12-12
FR2714604B1 (fr) 1996-01-26
HUT71385A (en) 1995-11-28
CA2138877A1 (fr) 1995-07-01
US5569663A (en) 1996-10-29
EP0665003A1 (fr) 1995-08-02
US5679691A (en) 1997-10-21
DE69400431T2 (de) 1997-01-16
FR2714604A1 (fr) 1995-07-07
DE69400431D1 (de) 1996-10-02
CN1114876A (zh) 1996-01-17
RU2139038C1 (ru) 1999-10-10
EP0665003B1 (fr) 1996-08-28

Similar Documents

Publication Publication Date Title
ES2094035T3 (es) Utilizacion de un aceptor de espin en una composicion cosmetica o dermatologica.
DE69400337D1 (de) Mittel gegen Hautalterung, das gleichzeitig auf die Hautoberschichten und Tiefschichten wirkt
AU7617387A (en) Treatment of keratinous fibres
ATE144132T1 (de) Topische schlankheitsmittel enthaltend zwei verschiedenartigen liposomen, sowie anwendung
FR2714596B1 (fr) Composition cosmétique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
ATE278378T1 (de) Zusammensetzung für die direktziehende färbung von keratinischen fäsern mit einem direkziehenden kationischen farbstoff und einem polyol und/oder einem polyether
FR2714601B1 (fr) Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.
ATE281152T1 (de) Verwendung von glycoglycerolipiden als tenside sowie kosmetische oder dermatologische zubereitungen, solche glycoglycerolipide enthaltend
BR0115461A (pt) Composição de tintura de oxidação das fibras queratìnicas, composição pronta para o uso, processo de tintura das fibras queratìnicas, dispositivo com 2 compartimentos ou &#39;kit&#39; para a tintura das fibras queratìnicas humanas e dispositivo com 3 compartimentos para a tintura das fibras queratìnicas humanas
ES2086935T3 (es) Composicion cosmetica o dermatologica en forma de una dispersion aceite en agua susceptible de formar peliculas compuestas.
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
BR9806222A (pt) Composição cosmética e/ou dermatológica destinada ao tratamento das fibras queratìnicas, composição pronta para o uso, processo de tintura e de tratamento das fibras queratìnicas e dispositivos ou &#34;kit&#34; de tintura com vários compartimentos
DE59003020D1 (de) Piroxicam enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
DE69600410T2 (de) Verwendung von Procystein als depigmentierendes Mittel
BR9705279A (pt) Utilização de um organossiloxano e processo de tratamento cosmético.
DE59403187D1 (de) Verwendung von 1,8-dihydroxynaphthalinen als oxidationsfarbstoffvorprodukte in oxidationsfärbemitteln
AU689117B2 (en) Shower lotions for dry skin treatment and care
ES2102283T3 (es) Composicion de teñido por oxidacion de fibras queratinicas y procedimiento de teñido que utiliza esta composicion.
ES2099613T3 (es) Empleo de hidroxinaftalinas en agentes colorantes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 665003

Country of ref document: ES